“Early 2026 witnesses a surge in US securities issuances, with corporate bonds hitting $50 billion in new deals, including $39.9 billion from investment-grade issuers. Treasury auctions feature bills with rates around 3.5-3.6% and notes yielding up to 4.173%. IPO activity includes notable filings like Aktis Oncology, alongside SPACs and smaller entities. Municipal supply is projected at $600 billion for the year, bolstered by issuances such as New York State Thruway Authority’s $833 million bonds. Overall forecasts indicate 5% global issuance growth, driven by refinancing maturities and economic tailwinds.”
Corporate Bond Market
The corporate bond sector has kicked off 2026 with vigorous activity, reflecting issuers’ efforts to capitalize on stable interest rates and investor appetite for yield. Primary market deals have already totaled $50 billion, dominated by investment-grade offerings that account for $39.9 billion across numerous issuers. This pace aligns with expectations of sustained high volumes, as companies face upcoming maturity walls requiring refinancing.
High-profile international players have also tapped US dollar markets, such as a major telecom firm’s $6 billion multi-tranche bond placement, underscoring the appeal of dollar-denominated debt amid global uncertainties. Commercial real estate collateralized loan obligations (CRE CLOs) are accelerating, with reinvestments holding firm and performance metrics remaining stable, indicating resilience in property-backed securities.
Treasury Securities
US Treasury issuances continue to serve as a benchmark for fixed-income markets, with recent auctions drawing strong demand. Short-term bills have seen consistent bidding, with rates reflecting a cautious economic outlook. Below is a summary of key recent Treasury bill and note issuances:
| Security Type | CUSIP | Issue Date | Maturity Date | High Rate/Yield | Interest Rate |
|---|---|---|---|---|---|
| 4-Week Bill | 912797SQ1 | 01/13/2026 | 02/10/2026 | 3.550% | – |
| 8-Week Bill | 912797SY4 | 01/13/2026 | 03/10/2026 | 3.540% | – |
| 17-Week Bill | 912797TR8 | 01/13/2026 | 05/12/2026 | 3.510% | – |
| 6-Week Bill | 912797PM3 | 01/08/2026 | 02/19/2026 | 3.560% | – |
| 13-Week Bill | 912797SL2 | 01/08/2026 | 04/09/2026 | 3.540% | – |
| 26-Week Bill | 912797RF6 | 01/08/2026 | 07/09/2026 | 3.475% | – |
| 3-Year Note | 91282CPT2 | 01/15/2026 | 01/15/2029 | 3.609% | 3.500% |
| 10-Year Note (Reopening) | 91282CPJ4 | 01/15/2026 | 11/15/2035 | 4.173% | 4.000% |
These auctions highlight investor preference for shorter maturities amid expectations of gradual Federal Reserve policy adjustments.
Initial Public Offerings
Equity markets are showing renewed vigor with a pipeline of IPOs, building on 2025’s momentum where venture-backed firms raised over $16 billion. Early 2026 has seen filings and pricings from diverse sectors, including biotech and acquisition vehicles.
Key recent and upcoming IPOs include:
Aktis Oncology: Leading as the year’s first sizable offering, focusing on targeted radiotherapeutics.
Jaguar Uranium Corp. (JAGU): Filed for listing, targeting resource extraction.
Invea Therapeutics, Inc. (INAI): Biotech firm emphasizing AI-driven drug discovery.
K2 Capital Acquisition Corp. (KTWOU): SPAC aimed at mergers in growth industries.
Atlas Critical Minerals (ATCX): Uplisting in mining sector.
Buda Juice, Inc. (BUDA): Consumer goods entry.
Soren Acquisition Corp. (SORN): Another SPAC vehicle.
Art Technology Acquisition Corp. (ARTC): Tech-focused blank-check company.
Leapfrog Acquisition Corp. (LFACU): SPAC with broad acquisition mandate.
This activity suggests a robust outlook, with valuations recovering and a strong queue for 2026-2027, potentially driving S&P 500 gains toward 7,800.
Municipal Bonds
The muni market anticipates record supply of $600 billion in 2026, fueled by infrastructure needs and tax-exempt appeal. Notable issuances include the New York State Thruway Authority’s $833 million general revenue bonds, rated A1/A, which support transportation upgrades. This segment remains attractive for yield-seeking investors in a higher-for-longer rate environment.
Market Outlook
Projections for 2026 point to moderated growth in global issuances at around 5%, following 12% expansion in 2025. US equities are poised to outperform, with fixed-income strategies emphasizing resilience amid potential volatility. Increased liability management and CRE CLO momentum could further shape dynamics, as issuers navigate policy shifts and economic signals.
Disclaimer: This news report is for informational purposes only and does not constitute financial advice or investment recommendations. All tips and insights are based on general market observations from publicly available sources.